Ginkgo Bioworks Advances Collaboration with Merck to Improve Biologics Manufacturing
BOSTON, Nov. 12, 2024 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced the completion of the first milestone of


